See the DrugPatentWatch profile for Menopur
The trademark owner for Menopur is Ferring Pharmaceuticals [1].
What is Menopur used for?
Menopur is a prescription medication used to stimulate ovulation and sperm production [2]. It contains menotropins, which are gonadotropins derived from the urine of postmenopausal women [3].
How does Menopur work?
Menopur contains two key hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH) [3]. In women, these hormones stimulate the development of ovarian follicles, which contain eggs [3]. In men, they stimulate sperm production in the testes [3].
When does the patent for Menopur expire?
Patent information for Menopur can be complex and may involve multiple patents covering different aspects of the drug, such as formulation, manufacturing, and specific uses. DrugPatentWatch.com tracks patent expirations for pharmaceuticals [4]. Specific expiry dates are best found by consulting detailed patent databases.
Are there other fertility treatments available?
Yes, several other fertility treatments exist. These include other injectable gonadotropins, oral medications, and assisted reproductive technologies such as in vitro fertilization (IVF) [5].
Who are Ferring Pharmaceuticals' competitors in the fertility market?
Ferring Pharmaceuticals faces competition from other companies that manufacture and market fertility drugs and treatments. These competitors offer a range of gonadotropins and other fertility-related products [6].
What is the typical cost of Menopur?
The cost of Menopur can vary significantly depending on dosage, duration of treatment, insurance coverage, and geographic location. It is typically administered by injection and is considered a significant expense for fertility treatments [7].
Are there potential side effects of Menopur?
Common side effects of Menopur can include abdominal pain, bloating, nausea, vomiting, diarrhea, headaches, and injection site reactions [2]. In women, a risk of ovarian hyperstimulation syndrome (OHSS) exists, which can be severe [2].
What is the regulatory status of Menopur?
Menopur is approved by regulatory agencies in various countries, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), for specific indications related to infertility treatment [2][3].
Can generics or biosimilars of Menopur be produced?
As a biological product, Menopur is subject to complex patent and regulatory pathways for generic or biosimilar development. The ability to produce and market biosimilar versions depends on patent expiry and the successful completion of regulatory approval processes, which often require demonstrating high similarity to the original product [8].
How is Menopur administered?
Menopur is typically administered by subcutaneous injection, meaning it is injected just under the skin [2]. It is usually self-administered at home after proper training [9].
What clinical data supports Menopur's use?
Clinical trials have been conducted to evaluate the efficacy and safety of Menopur in stimulating ovulation and sperm production [3]. The results of these studies inform its approved uses and prescribing information.
Sources:
[1] https://www.ferring.com/
[2] https://www.drugs.com/menopur.html
[3] https://www.ncbi.nlm.nih.gov/books/NBK555903/
[4] https://drugpatentwatch.com/
[5] https://www.mayoclinic.org/diseases-conditions/infertility/diagnosis-treatment/drc-20354319
[6] Market research reports on the fertility drugs market.
[7] Patient forums and pharmaceutical pricing information websites.
[8] https://www.fda.gov/media/108150/download
[9] https://www.goodrx.com/menopur